Carla Minoia, MD

Hematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Italy

Poster(s):

• 1709 - Impact of Dose Intensity of Ibrutinib on Clinical Outcomes of CLL Patients: Analysis of the EVIdeNCE Study